A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -44.09% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 31.89%. Over the past 30 days, the price of LRMR has fallen by 33.13%. And in the last five days, it has surged by 16.39%.
The stock of Larimar Therapeutics Inc (LRMR) is currently priced at $4.26. In the last session, the stock climbed significantly, topping out at $33.0 after opening at $4.26. The day’s lowest price was $10.0 before the stock closed at $3.72.
Larimar Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $9.50 on 11/11/24, while the lowest value for the same period was recorded at $1.61 on 04/09/25.
52-week price history of LRMR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Larimar Therapeutics Inc’s current trading price is -55.16% away from its 52-week high, while its distance from the 52-week low is 164.60%. The stock’s price range during this period has varied between$1.61 and $9.50. The Larimar Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.58 million for the day, a figure considerably higher than their average daily volume of 1.32 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Larimar Therapeutics Inc (LRMR) has experienced a quarterly rise of 137.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 352.63M and boasts a workforce of 65 employees.
Larimar Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 10 analysts are rating Larimar Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.69, with a change in price of +1.72. Similarly, Larimar Therapeutics Inc recorded 1,321,907 in trading volume during the last 100 days, posting a change of +67.72%.
LRMR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LRMR stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
LRMR Stock Stochastic Average
Larimar Therapeutics Inc’s raw stochastic average for the past 50 days is presently 96.68%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 94.12%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 66.82% and 58.02%, respectively.
